利妥昔单抗对原发性抗磷脂综合征患者血小板减少症和抗心磷脂抗体的疗效有限。 - Suppr

Suppr

超能文献

Limited effect of rituximab on thrombocytopaenia and anticardiolipin antibodies in a patient with primary antiphospholipid syndrome.

作者信息

Ames P R J, Tommasino C, Fossati G, Scenna G, Brancaccio V, Ferrara F

出版信息

Ann Hematol. 2007 Mar;86(3):227-8. doi: 10.1007/s00277-006-0226-x. Epub 2006 Nov 21.

DOI:10.1007/s00277-006-0226-x

PMID:17119963

Abstract

摘要

相似文献

Limited effect of rituximab on thrombocytopaenia and anticardiolipin antibodies in a patient with primary antiphospholipid syndrome.利妥昔单抗对原发性抗磷脂综合征患者血小板减少症和抗心磷脂抗体的疗效有限。

Ann Hematol. 2007 Mar;86(3):227-8. doi: 10.1007/s00277-006-0226-x. Epub 2006 Nov 21.

Rituximab treatment for resistant antiphospholipid syndrome.利妥昔单抗治疗难治性抗磷脂综合征。

J Rheumatol. 2006 Feb;33(2):355-7.

Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab--monitoring of antiphospholipid and anti-GP antibodies: a case report.利妥昔单抗（抗CD20抗体）成功治疗原发性抗磷脂抗体综合征中的血小板减少症——抗磷脂抗体和抗糖蛋白抗体的监测：病例报告

Ann Hematol. 2006 Feb;85(2):134-5. doi: 10.1007/s00277-005-0028-6. Epub 2005 Nov 15.

[Risk of thrombosis with increased anticardiolipin antibodies].

Dtsch Med Wochenschr. 1997 Apr 11;122(15):492-3.

[Primary antiphospholipid syndrome].[原发性抗磷脂综合征]

Oftalmologia. 2008;52(1):13-7.

'Cure' of life-threatening antiphospholipid syndrome with rituximab.

Intern Med J. 2006 Jul;36(7):474-5. doi: 10.1111/j.1445-5994.2006.01113.x.

The role of IgM isotype anticardiolipin antibodies in occlusive ocular vascular disease: report of two cases with primary antiphospholipid antibody syndrome.IgM 同种型抗心磷脂抗体在闭塞性眼部血管疾病中的作用：两例原发性抗磷脂抗体综合征病例报告

Eye (Lond). 2000 Oct;14 Pt 5:789-90. doi: 10.1038/eye.2000.208.

Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome.利妥昔单抗诱导原发性抗磷脂抗体综合征患者复发性弥漫性肺泡出血缓解。

Lupus. 2012 Apr;21(4):438-40. doi: 10.1177/0961203311422713. Epub 2011 Oct 12.

Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab.婴儿疑似灾难性抗磷脂综合征，成功用利妥昔单抗治疗。

Pediatrics. 2010 Jun;125(6):e1523-8. doi: 10.1542/peds.2009-2939. Epub 2010 May 17.

[Antiphospholipid syndrome and lupus nephritis treated with rituximab].

Nefrologia. 2007;27(5):560-4.

引用本文的文献

The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome.利妥昔单抗对抗磷脂综合征患者抗磷脂抗体滴度的影响。

TH Open. 2023 Jul 5;7(3):e191-e194. doi: 10.1055/s-0043-1770784. eCollection 2023 Jul.

Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?抗磷脂综合征的免疫抑制治疗：是否值得？

Biomedicines. 2021 Feb 1;9(2):132. doi: 10.3390/biomedicines9020132.

Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.成功的血浆置换联合利妥昔单抗治疗侵袭性 APS 相关皮肤坏死。

Clin Rheumatol. 2013 Mar;32 Suppl 1:S79-82. doi: 10.1007/s10067-010-1506-3. Epub 2010 Jun 17.

Use of rituximab in the antiphospholipid syndrome.利妥昔单抗在抗磷脂综合征中的应用。

Curr Rheumatol Rep. 2010 Feb;12(1):40-4. doi: 10.1007/s11926-009-0074-5.

Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.抗磷脂抗体与动脉粥样硬化：来自系统性红斑狼疮和原发性抗磷脂综合征的见解

Clin Rev Allergy Immunol. 2009 Aug;37(1):29-35. doi: 10.1007/s12016-008-8099-5.

The potential utility of B cell-directed biologic therapy in autoimmune diseases.B细胞导向生物疗法在自身免疫性疾病中的潜在效用。

Rheumatol Int. 2008 Jan;28(3):205-15. doi: 10.1007/s00296-007-0471-x. Epub 2007 Oct 24.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.《2007年关于治疗风湿性疾病生物制剂的更新共识声明》

Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii2-22. doi: 10.1136/ard.2007.081430.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验